FibroBiologics FBLG
NASDAQ FBLG
$1.02 +0.02 (+2.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

FibroBiologics (FBLG) Current Debt (2024 - 2025)

Updated

FibroBiologics' Current Debt was $300,000 in FY2023, compared with -$300,000 in FY2022.

Analysis

FibroBiologics (FBLG) Current Debt (2024 - 2025) Analysis & Trends

  • Per Business Quant data, Current Debt in earlier years was -$300,000 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Debt (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 3.51 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn -4.36 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 208.00 Mn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn -
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 64.00 Mn
10 FibroBiologics 6.40 Mn -8.42 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -4.38 Mn
Dec 31, 2024 -115,000.00
Sep 30, 2024 -172,000.00
Jun 30, 2024 -172,000.00
Mar 31, 2024 459,000.00
API Access

FibroBiologics Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-debt&ticker=FBLG&period=max&api_key=YOUR_API_KEY